跳至主要内容
临床试验/CTRI/2023/11/060170
CTRI/2023/11/060170尚未招募Unknown

Cognitive Deficits in Alcohol Dependence Syndrome (ADS) Patients with and without Adverse Childhood Experiences (ACE). - NI

Mota Prachi Himansu Anila0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Group 1 (ADS + ACE)
  • 1.Individuals diagnosed with ADS
  • 2.ADS for minimum 5 years based on ICD-11 Criteria (abstinent for at least 1 week- CIWA score less than 9)
  • 3.Individuals with a frequency score of at least 1 on ACE-IQ
  • 4.Males aged 18- 50 years
  • 5.Abstinence of less than 1 year
  • 6.At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada
  • Group 2 (ACE)
  • 1.Individuals without ADS.
  • 2.Individuals with a frequency score of at least 1on the ACE-IQ
  • 3.Matched group (based of age and education) of males aged 18- 50 years
  • 4.At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada
  • Group 3 (ADS)
  • 1.Individuals diagnosed with ADS
  • 2.ADS for minimum 5 years based on ICD-11 Criteria (abstinent for at least 1 week- CIWA score less than 9)
  • 3.Individuals with a frequency score of 0 on ACE-IQ.
  • 4.Matched group (based of age and education) of males aged 18- 50 years
  • 5.Abstinence of less than 1 year
  • 6.At least 5 years of formal education (5th standard reading level) and ability to read, write and speak in English or Kannada

排除标准

  • Group 1 (ADS + ACE)
  • 1.Other substance disorders (except nicotine)
  • 2.Major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders)
  • 3.Individuals with severe cognitive deficits, for instance, individuals with Korsakoff’s syndrome, which may hinder the quality and accuracy of data collection.
  • 4.Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy.
  • 5.Other major medical comorbidities which may affect cognitive functioning.
  • Group 2 (ACE)
  • 1.Any Disorders due to Substance Use
  • 2.Other major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders)
  • 3.Individuals with severe cognitive deficits, for instance, individuals with dementia, which may hinder the quality and accuracy of data collection.
  • 4.Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy.
  • 5.Other major medical comorbidities which may affect cognitive functioning.
  • Group 3 (ADS)
  • 1.Individuals with a frequency score of 1 or more on ACE-IQ.
  • 2.Other substance disorders (except nicotine)
  • 3.Major psychiatric disorders (moderate to severe mood disorders, psychotic disorders, and anxiety disorders)
  • 4.Individuals with severe cognitive deficits, for instance, individuals with Korsakoff’s syndrome, which may hinder the quality and accuracy of data collection.
  • 5.Individuals with major neurological conditions including traumatic brain injury, road traffic accidents, epilepsy.
  • 6.Other major medical comorbidities which may affect cognitive functioning.

研究者

发起方
Mota Prachi Himansu Anila

相似试验